Ligand · I02
I02 · 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide
I02, 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide (C28 H30 F N5 O4 S, 551.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1…
- Component
- I02
- Formula
- C28 H30 F N5 O4 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
I02 in 2 structures; the first of them:
- 2IRZ · Crystal structure of human Beta-secretase complexed with inhibitor · I02 A386 · binds GLY11, GLN12, GLY13, TYR14, LEU30, ASP32, GLY34, SER35 and 19 more
- 2IRZ · Crystal structure of human beta-secretase complexed with inhibitor · I02 A386 · binds GLY11, GLN12, GLY13, TYR14, LEU30, ASP32, GLY34, SER35 and 19 more
Residues it binds most
GLY 2, SER 2, THR 2, ARG 2, ASP 2, GLN 2, ILE 2, TYR 2, ALA 2, ASN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.